XNAS 05 May, 2026 4:18 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Mansoor Raza Mirza | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 174,068 | 174,068 | - | - | Stock Option (Right to Buy) | |
| Adam Levy | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 132,925 | 132,925 | - | - | Stock Option (Right to Buy) | |
| Peter Blume-Jensen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 417,210 | 417,210 | - | - | Stock Option (Right to Buy) | |
| Peter Blume-Jensen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 185,495 | 185,495 | - | - | Stock Option (Right to Buy) | |
| Erick Gamelin | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 94,946 | 94,946 | - | - | Stock Option (Right to Buy) | |
| Eric Devroe | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 186,728 | 186,728 | - | - | Stock Option (Right to Buy) | |
| Katharine Peterson | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2026 | 31,900 | 31,900 | - | - | Stock Option (Right to Buy) | |
| Peter Blume-Jensen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.53 per share. | 21 Feb 2026 | 14,265 | 2,080,204 | - | 1.5 | 21,825 | Common Stock |
| Peter Blume-Jensen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. | 14 Feb 2026 | 579 | 314,127 | - | 1.6 | 944 | Common Stock |
| Peter Blume-Jensen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. | 14 Feb 2026 | 1,302 | 2,094,469 | - | 1.6 | 2,122 | Common Stock |
| Erick Gamelin | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. | 14 Feb 2026 | 471 | 14,812 | - | 1.6 | 768 | Common Stock |
| Eric Devroe | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. | 14 Feb 2026 | 723 | 74,585 | - | 1.6 | 1,178 | Common Stock |
| Katharine Peterson | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.63 per share. | 14 Feb 2026 | 116 | 4,006 | - | 1.6 | 189 | Common Stock |
| Adam Levy | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 1.70 per share. | 14 Jan 2026 | 8,832 | 20,983 | - | 1.7 | 14,999 | Common Stock |
| Peter Blume-Jensen | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 1.68 per share. | 14 Jan 2026 | 49,000 | 2,095,771 | - | 1.7 | 82,124 | Common Stock |
| Eric Devroe | Chief Operating Officer | Purchase of securities on an exchange or from another person at price $ 1.72 per share. | 13 Jan 2026 | 10,000 | 75,308 | - | 1.7 | 17,218 | Common Stock |
| Peter Blume-Jensen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.30 per share. | 21 Nov 2025 | 19,904 | 2,046,771 | - | 2.3 | 45,779 | Common Stock |
| Peter Blume-Jensen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.24 per share. | 14 Nov 2025 | 490 | 314,706 | - | 2.2 | 1,098 | Common Stock |
| Peter Blume-Jensen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.24 per share. | 14 Nov 2025 | 59,765 | 2,066,675 | - | 2.2 | 133,874 | Common Stock |
| Erick Gamelin | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.24 per share. | 14 Nov 2025 | 403 | 15,283 | - | 2.2 | 903 | Common Stock |
| Eric Devroe | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.24 per share. | 14 Nov 2025 | 613 | 65,308 | - | 2.2 | 1,373 | Common Stock |
| Katharine Peterson | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.24 per share. | 14 Nov 2025 | 99 | 4,122 | - | 2.2 | 222 | Common Stock |
| Mansoor Raza Mirza | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2025 | 225,000 | 225,000 | - | - | Stock Option (Right to Buy) | |
| Peter Blume-Jensen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.32 per share. | 21 Aug 2025 | 19,905 | 2,126,440 | - | 1.3 | 26,275 | Common Stock |
| Peter Blume-Jensen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.39 per share. | 14 Aug 2025 | 59,766 | 2,146,345 | - | 1.4 | 83,075 | Common Stock |
| Peter Blume-Jensen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.39 per share. | 14 Aug 2025 | 490 | 315,196 | - | 1.4 | 681 | Common Stock |
| Erick Gamelin | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.39 per share. | 14 Aug 2025 | 403 | 15,686 | - | 1.4 | 560 | Common Stock |
| Eric Devroe | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.39 per share. | 14 Aug 2025 | 613 | 65,921 | - | 1.4 | 852 | Common Stock |
| Katharine Peterson | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.39 per share. | 14 Aug 2025 | 99 | 4,221 | - | 1.4 | 138 | Common Stock |
| Adam Levy | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.26 per share. | 01 Aug 2025 | 1,164 | 12,151 | - | 1.3 | 1,467 | Common Stock |
| Michael J. Tomsicek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 20,275 | 20,275 | - | - | Stock Option (Right to Buy) | |
| Charles M. Baum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 20,275 | 20,275 | - | - | Stock Option (Right to Buy) | |
| Sharon Shacham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 20,275 | 20,275 | - | - | Stock Option (Right to Buy) | |
| Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 20,275 | 20,275 | - | - | Stock Option (Right to Buy) | |
| Santhosh Palani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2025 | 20,275 | 20,275 | - | - | Stock Option (Right to Buy) | |
| Peter Blume-Jensen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.15 per share. | 21 May 2025 | 19,904 | 2,206,111 | - | 1.2 | 22,890 | Common Stock |
| Peter Blume-Jensen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. | 14 May 2025 | 491 | 315,686 | - | 1.1 | 560 | Common Stock |
| Peter Blume-Jensen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. | 14 May 2025 | 59,766 | 2,226,015 | - | 1.1 | 68,133 | Common Stock |
| Erick Gamelin | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. | 14 May 2025 | 403 | 16,089 | - | 1.1 | 459 | Common Stock |
| Eric Devroe | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. | 14 May 2025 | 613 | 66,534 | - | 1.1 | 699 | Common Stock |
| Katharine Peterson | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. | 14 May 2025 | 99 | 4,320 | - | 1.1 | 113 | Common Stock |
| Adam Levy | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 35,209 | 35,209 | - | - | Stock Option (Right to Buy) | |
| Jean-Marie Cuillerot | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 78,078 | 78,078 | - | - | Stock Option (Right to Buy) | |
| Peter Blume-Jensen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 140,540 | 140,540 | - | - | Stock Option (Right to Buy) | |
| Peter Blume-Jensen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 390,390 | 390,390 | - | - | Stock Option (Right to Buy) | |
| Rasmus Holm-Jorgensen | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 109,309 | 109,309 | - | - | Stock Option (Right to Buy) | |
| Erick Gamelin | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 78,078 | 78,078 | - | - | Stock Option (Right to Buy) | |
| Eric Devroe | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 140,540 | 140,540 | - | - | Stock Option (Right to Buy) | |
| Katharine Peterson | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2025 | 31,900 | 31,900 | - | - | Stock Option (Right to Buy) | |
| Peter Blume-Jensen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.54 per share. | 21 Feb 2025 | 19,904 | 2,285,781 | - | 5.5 | 110,268 | Common Stock |
| Peter Blume-Jensen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.42 per share. | 14 Feb 2025 | 37,152 | 2,305,685 | - | 5.4 | 201,364 | Common Stock |
| Peter Blume-Jensen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.42 per share. | 14 Feb 2025 | 579 | 316,177 | - | 5.4 | 3,138 | Common Stock |
| Rasmus Holm-Jorgensen | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.42 per share. | 14 Feb 2025 | 434 | 26,088 | - | 5.4 | 2,352 | Common Stock |
| Erick Gamelin | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.42 per share. | 14 Feb 2025 | 469 | 16,492 | - | 5.4 | 2,542 | Common Stock |
| Eric Devroe | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.42 per share. | 14 Feb 2025 | 724 | 67,147 | - | 5.4 | 3,924 | Common Stock |
| Katharine Peterson | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.42 per share. | 14 Feb 2025 | 116 | 4,419 | - | 5.4 | 629 | Common Stock |
| Peter Blume-Jensen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.44 per share. | 21 Nov 2024 | 19,910 | 2,342,837 | - | 6.4 | 128,220 | Common Stock |
| Peter Blume-Jensen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.92 per share. | 14 Nov 2024 | 59,766 | 2,362,747 | - | 7.9 | 473,347 | Common Stock |
| Peter Blume-Jensen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.92 per share. | 14 Nov 2024 | 490 | 316,756 | - | 7.9 | 3,881 | Common Stock |
| Rasmus Holm-Jorgensen | Chief Financial Officer | 14 Nov 2024 | 368 | 26,522 | - | 7.9 | 2,915 | Common Stock | |
| Erick Gamelin | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.92 per share. | 14 Nov 2024 | 402 | 16,961 | - | 7.9 | 3,184 | Common Stock |
| Eric Devroe | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.92 per share. | 14 Nov 2024 | 613 | 67,871 | - | 7.9 | 4,855 | Common Stock |
| Katharine Peterson | Chief Accounting Officer | 14 Nov 2024 | 99 | 4,535 | - | 7.9 | 784 | Common Stock | |
| Peter Blume-Jensen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.19 per share. | 21 Aug 2024 | 79,616 | 2,422,513 | - | 9.2 | 731,671 | Common Stock |
| Peter Blume-Jensen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.02 per share. | 14 Aug 2024 | 59,765 | 2,502,129 | - | 7.0 | 419,550 | Common Stock |
| Rasmus Holm-Jorgensen | Chief Financial Officer | 14 Aug 2024 | 368 | 26,890 | - | 7.0 | 2,583 | Common Stock | |
| Erick Gamelin | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.02 per share. | 14 Aug 2024 | 402 | 17,363 | - | 7.0 | 2,822 | Common Stock |
| Kristina Masson | Director, EVP - Business Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.02 per share. | 14 Aug 2024 | 490 | 317,246 | - | 7.0 | 3,440 | Common Stock |
| Eric Devroe | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.02 per share. | 14 Aug 2024 | 613 | 68,484 | - | 7.0 | 4,303 | Common Stock |
| Katharine Peterson | Chief Accounting Officer | 14 Aug 2024 | 99 | 4,634 | - | 7.0 | 695 | Common Stock | |
| Michael J. Tomsicek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 20,275 | 20,275 | - | - | Stock Option (Right to Buy) | |
| Charles M. Baum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 20,275 | 20,275 | - | - | Stock Option (Right to Buy) | |
| Sharon Shacham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 20,275 | 20,275 | - | - | Stock Option (Right to Buy) | |
| Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 20,275 | 20,275 | - | - | Stock Option (Right to Buy) | |
| Eric Devroe | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. | 17 May 2024 | 10,000 | 69,097 | - | 1.0 | 10,400 | Common Stock |
| Eric Devroe | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2024 | 10,000 | 86,615 | - | - | Stock Option (Right to Buy) | |
| Peter Blume-Jensen | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.36 per share. | 14 May 2024 | 54,918 | 2,561,894 | - | 8.4 | 459,114 | Common Stock |
| Rasmus Holm-Jorgensen | Chief Financial Officer | 14 May 2024 | 368 | 27,258 | - | 8.4 | 3,076 | Common Stock | |
| Erick Gamelin | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.36 per share. | 14 May 2024 | 402 | 17,765 | - | 8.4 | 3,361 | Common Stock |
| Kristina Masson | Director, EVP - Business Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.36 per share. | 14 May 2024 | 490 | 317,736 | - | 8.4 | 4,096 | Common Stock |
| Eric Devroe | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.36 per share. | 14 May 2024 | 613 | 59,097 | - | 8.4 | 5,125 | Common Stock |
| Katharine Peterson | Chief Accounting Officer | 14 May 2024 | 99 | 4,733 | - | 8.4 | 828 | Common Stock | |
| Santhosh Palani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2024 | 32,500 | 32,500 | - | - | Stock Option (Right to Buy) | |
| Gamelin Erick | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 45,045 | 45,045 | - | - | Stock Option (Right to Buy) | |
| Devroe Eric | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 90,090 | 90,090 | - | - | Stock Option (Right to Buy) | |
| Blume-Jensen Peter | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 90,090 | 90,090 | - | - | Stock Option (Right to Buy) | |
| Rasmus Holm-Jorgensen | Chief Financial Officer | 01 Mar 2024 | 90,090 | 90,090 | - | - | Stock Option (Right to Buy) | ||
| Peter Blume-Jensen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 225,226 | 225,226 | - | - | Stock Option (Right to Buy) | |
| Erick Gamelin | Chief Development Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.40 per share. | 14 Feb 2024 | 468 | 18,167 | - | 3.4 | 1,591 | Common Stock |
| Rasmus Holm-Jorgensen | Chief Financial Officer | 14 Feb 2024 | 434 | 27,626 | - | 3.4 | 1,476 | Common Stock | |
| Blume-Jensen Peter | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.40 per share. | 14 Feb 2024 | 41,861 | 2,616,812 | - | 3.4 | 142,327 | Common Stock |
| Eric Devroe | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.40 per share. | 14 Feb 2024 | 723 | 59,710 | - | 3.4 | 2,458 | Common Stock |
| Masson Kristina | Director, EVP - Business Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.40 per share. | 14 Feb 2024 | 579 | 318,226 | - | 3.4 | 1,969 | Common Stock |
| Jean-Marie Cuillerot | Chief Medical Officer | 11 Jan 2024 | 99,300 | 99,300 | - | - | Stock Option (Right to Buy) | ||
| Peter Blume-Jensen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Aug 2023 | 493,994 | 2,897,696 | - | 0 | Common Stock | |
| Charles M. Baum | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 32,500 | 32,500 | - | - | Stock Option (Right to Buy) | |
| Rasmus Holm-Jorgensen | Chief Financial Officer | 16 Jun 2023 | 9,500 | 183,119 | - | - | Stock Option (Right to Buy) | ||
| Rasmus Holm-Jorgensen | Chief Financial Officer | 16 Jun 2023 | 9,500 | 29,530 | - | 3.6 | 34,485 | Common Stock | |
| Eric Devroe | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jun 2023 | 9,225 | 96,615 | - | - | Stock Option (Right to Buy) | |
| Eric Devroe | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.04 per share. | 05 Jun 2023 | 9,225 | 62,883 | - | 1.0 | 9,594 | Common Stock |
| Peter Blume-Jensen | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.88 per share. | 31 May 2023 | 33,605 | 2,403,702 | - | 3.9 | 130,387 | Common Stock |
| Peter Blume-Jensen | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 33,605 | 90,855 | - | - | Stock Option (Right to Buy) | |
| Michael J. Tomsicek | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 35,235 | 35,235 | - | - | Stock Option (Right to Buy) | |
| Sharon Shacham | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 35,235 | 35,235 | - | - | Stock Option (Right to Buy) | |
| Derek DiRocco | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 35,235 | 35,235 | - | - | Stock Option (Right to Buy) | |
| Peter Blume-Jensen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 503,419 | 2,310,007 | - | 0 | Common Stock | |
| Peter Blume-Jensen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 934,731 | 1,806,588 | - | 0 | Common Stock | |
| Peter Blume-Jensen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 60,090 | 2,370,097 | - | 0 | Common Stock | |
| Peter Blume-Jensen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 26,707 | 320,705 | - | 0 | Common Stock | |
| Peter Blume-Jensen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 180,269 | 180,269 | - | - | Stock Option (Right to Buy) | |
| Peter Blume-Jensen | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 80,120 | 80,120 | - | - | Stock Option (Right to Buy) | |
| Rasmus Holm-Jorgensen | Chief Financial Officer | 14 Nov 2022 | 60,090 | 60,090 | - | - | Stock Option (Right to Buy) | ||
| Rasmus Holm-Jorgensen | Chief Financial Officer | 14 Nov 2022 | 20,030 | 20,030 | - | 0 | Common Stock | ||
| Erick Gamelin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 20,030 | 20,030 | - | 0 | Common Stock | |
| Erick Gamelin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 60,090 | 60,090 | - | - | Stock Option (Right to Buy) | |
| Kristina Masson | Director, EVP - Business Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 26,707 | 320,705 | - | 0 | Common Stock | |
| Kristina Masson | Director, EVP - Business Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 934,731 | 1,806,588 | - | 0 | Common Stock | |
| Kristina Masson | Director, EVP - Business Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 503,419 | 2,310,007 | - | 0 | Common Stock | |
| Kristina Masson | Director, EVP - Business Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 80,120 | 80,120 | - | - | Stock Option (Right to Buy) | |
| Kristina Masson | Director, EVP - Business Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 180,269 | 180,269 | - | - | Stock Option (Right to Buy) | |
| Kristina Masson | Director, EVP - Business Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 60,090 | 2,370,097 | - | 0 | Common Stock | |
| Eric Devroe | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 33,383 | 53,658 | - | 0 | Common Stock | |
| Eric Devroe | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 100,150 | 100,150 | - | - | Stock Option (Right to Buy) |